Sophia Randolph - 25 Jul 2023 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer, Director
Signature
/s/ Peter Garcia, by power of attorney
Issuer symbol
ALXO
Transactions as of
25 Jul 2023
Net transactions value
$0
Form type
4
Filing time
27 Jul 2023, 16:27:05 UTC
Previous filing
05 Jul 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXO Common Stock Award +34,000 +12% 315,477 25 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Common Stock Award $0 +107,000 $0.000000 107,000 25 Jul 2023 Common Stock 107,000 $5.86 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023.
F2 Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023.